R16	Appositive Attribute:T217 Head:T26
R17	Anaphora Anaphor:T99 Antecedent:T35
R18	Anaphora Anaphor:T136 Antecedent:T49
R19	Anaphora Anaphor:T137 Antecedent:T136
R20	Anaphora Anaphor:T225 Antecedent:T29
R21	Anaphora Anaphor:T232 Antecedent:T231
R22	Anaphora Anaphor:T234 Antecedent:T90
R23	Anaphora Anaphor:T234 Antecedent:T93
R24	Anaphora Anaphor:T234 Antecedent:T91
R25	Anaphora Anaphor:T234 Antecedent:T92
R26	Cataphora Cataphor:T233 Consequent:T90
R27	Cataphora Cataphor:T233 Consequent:T93
R28	Cataphora Cataphor:T233 Consequent:T91
R29	Cataphora Cataphor:T233 Consequent:T92
T1	Drug_Class 6132 6151	vasodilating agents
T2	Drug 6160 6168	LETAIRIS
T3	Drug_Class 7195 7226	endothelin receptor antagonists
T4	Drug 7235 7243	LETAIRIS
T7	Drug 8861 8873	cyclosporine
T8	Drug 8922 8933	ambrisentan
T9	Drug 8995 9006	ambrisentan
T10	Drug 9052 9064	cyclosporine
T12	Drug 9203 9214	ambrisentan
T13	Drug 9150 9162	cyclosporine
T14	Drug 9273 9285	cyclosporine
T15	Drug_Class 2574 2605	endothelin receptor antagonists
T16	Drug_Class 3632 3663	endothelin receptor antagonists
T17	Drug_Class 5071 5102	endothelin receptor antagonists
T18	Drug_Class 7135 7166	endothelin receptor antagonists
T19	Drug_Class 7378 7409	endothelin receptor antagonists
T20	Drug_Class 5672 5680	diuretic
T21	Drug 10473 10480	alcohol
T22	Drug 47 58	AMBRISENTAN
T23	Drug 2227 2238	Ambrisentan
T24	Drug 8845 8856	ambrisentan
T25	Drug 9134 9145	ambrisentan
T26	Drug 9379 9390	ambrisentan
T27	Drug 9507 9518	ambrisentan
T29	Drug 9758 9769	Ambrisentan
T30	Drug 9857 9868	Ambrisentan
T31	Drug 10014 10025	ambrisentan
T32	Drug 10566 10577	ambrisentan
T33	Drug 10634 10645	ambrisentan
T34	Drug 26 34	Letairis
T35	Drug 103 111	LETAIRIS
T36	Drug 165 173	LETAIRIS
T37	Drug 432 440	LETAIRIS
T38	Drug 829 837	LETAIRIS
T39	Drug 951 959	LETAIRIS
T40	Drug 1019 1027	LETAIRIS
T44	Drug 1210 1218	LETAIRIS
T45	Drug 1336 1344	LETAIRIS
T46	Drug 1933 1941	LETAIRIS
T47	Drug 2158 2166	LETAIRIS
T48	Drug 2639 2647	LETAIRIS
T49	Drug 2667 2675	LETAIRIS
T50	Drug 2968 2976	LETAIRIS
T51	Drug 3120 3128	LETAIRIS
T52	Drug 3458 3466	LETAIRIS
T53	Drug 3864 3872	LETAIRIS
T54	Drug 3931 3939	LETAIRIS
T55	Drug 4047 4055	LETAIRIS
T56	Drug 4196 4204	LETAIRIS
T57	Drug 4436 4444	LETAIRIS
T58	Drug 4683 4691	LETAIRIS
T59	Drug 4775 4783	LETAIRIS
T60	Drug 4859 4867	LETAIRIS
T61	Drug 5298 5306	LETAIRIS
T62	Drug 5624 5632	LETAIRIS
T63	Drug 5933 5941	LETAIRIS
T64	Drug 6038 6046	LETAIRIS
T65	Drug 6261 6269	LETAIRIS
T66	Drug 7453 7461	LETAIRIS
T67	Drug 7538 7546	LETAIRIS
T68	Drug 7670 7678	LETAIRIS
T69	Drug 7895 7903	LETAIRIS
T70	Drug 8497 8505	LETAIRIS
T71	Drug 8564 8572	LETAIRIS
T72	Drug 8772 8780	LETAIRIS
T73	Drug 9348 9356	LETAIRIS
T74	Drug 10092 10100	LETAIRIS
T75	Drug 10533 10541	LETAIRIS
T76	Drug 10600 10608	LETAIRIS
T77	Drug 10647 10655	LETAIRIS
T78	Drug 2529 2536	thyroid
T83	Drug 6356 6364	bosentan
T90	Substance 10244 10265	croscarmellose sodium
T91	Substance 10267 10286	lactose monohydrate
T92	Substance 10288 10306	magnesium stearate
T93	Substance 10311 10337	microcrystalline cellulose
T241	SPAN 5356 5366	Most edema
T97	ZeroArticleNP 0 10	Drug Label
T98	ZeroArticleNP 15 34	drug brand Letairis
T99	PersonalPronoun 140 142	it
T100	IndefiniteNP 115 131	a pregnant woman
T101	PersonalPronoun 296 298	it
T102	DemonstrativeNP 252 263	this effect
T103	DefiniteNP 399 413	the initiation
T104	DefiniteNP 518 525	the use
T105	DefiniteNP 576 587	the patient
T106	IndefiniteNP 596 617	a tubal sterilization
T107	IndefiniteNP 636 655	a Copper T 380A IUD
T108	DefiniteNP 802 810	the risk
T109	DefiniteNP 947 969	the LETAIRIS Education
T110	IndefiniteNP 864 884	a restricted program
T111	IndefiniteNP 891 908	a Risk Evaluation
T112	DefiniteNP 1015 1032	the LETAIRIS REMS
T113	DefiniteNP 1087 1098	the program
T114	IndefiniteNP 1000 1011	a component
T115	DefiniteNP 1234 1256	the restricted program
T116	DefiniteNP 1290 1313	the required monitoring
T117	DefiniteNP 1468 1476	the dose
T118	ZeroArticleNP 1527 1534	Tablets
T119	DefiniteNP 1646 1654	the dose
T120	ZeroArticleNP 1697 1704	Tablets
T121	ZeroArticleNP 1747 1754	Tablets
T122	IndefiniteNP 1988 2013	a negative pregnancy test
T123	IndefiniteNP 2209 2225	a pregnant woman
T124	PersonalPronoun 2321 2323	it
T125	DefiniteNP 2401 2414	the lower jaw
T126	DefiniteNP 2457 2466	the heart
T127	DefiniteNP 2514 2524	the thymus
T128	DistributiveNP 2359 2371	both species
T129	IndefiniteNP 2556 2570	a class effect
T130	ZeroArticleNP 2574 2605	endothelin receptor antagonists
T131	DefiniteNP 2628 2635	the use
T132	DefiniteNP 2781 2792	the patient
T133	DefiniteNP 2834 2845	the patient
T134	DefiniteNP 2868 2888	the potential hazard
T135	IndefiniteNP 2892 2899	a fetus
T136	DemonstrativeNP 2739 2748	this drug
T137	DemonstrativeNP 2823 2832	this drug
T138	DefiniteNP 2935 2949	the initiation
T139	ZeroArticleNP 3445 3452	therapy
T140	ZeroArticleNP 3632 3663	endothelin receptor antagonists
T141	DefiniteNP 3723 3742	the first few weeks
T142	DefiniteNP 3837 3845	the risk
T143	DefiniteNP 3927 3949	the LETAIRIS Education
T144	IndefiniteNP 3899 3919	a restricted program
T145	ZeroArticleNP 3986 3996	components
T146	DefiniteNP 4070 4100	the LEAP Prescriber Enrollment
T147	DefiniteNP 4131 4142	the program
T148	DefiniteNP 4160 4181	the REMS requirements
T149	PossessivePronoun 4290 4306	their prescriber
T150	IndefiniteNP 4206 4218	all patients
T151	IndefiniteNP 4233 4258	a patient enrollment form
T152	PersonalPronoun 4489 4492	she
T153	PersonalPronoun 4595 4598	she
T154	PersonalPronoun 4701 4704	she
T155	PersonalPronoun 4745 4748	she
T156	DefiniteNP 4398 4412	the prescriber
T157	DefiniteNP 4629 4645	the requirements
T158	DefiniteNP 4649 4665	the REMS program
T159	DefiniteNP 4670 4679	the risks
T160	IndefiniteNP 4349 4365	a pregnancy test
T161	IndefiniteNP 4559 4575	a pregnancy test
T162	DistributiveNP 4529 4542	each shipment
T163	DefiniteNP 4883 4894	the program
T164	DefiniteNP 4920 4941	the REMS requirements
T165	IndefiniteNP 5047 5067	a known class effect
T166	IndefiniteNP 5116 5138	a clinical consequence
T167	ZeroArticleNP 5071 5102	endothelin receptor antagonists
T168	DefiniteNP 5168 5198	the placebo-controlled studies
T169	IndefiniteNP 5210 5232	an increased incidence
T170	PersonalPronoun 5405 5407	it
T171	IndefiniteNP 5670 5698	a diuretic, fluid management
T172	IndefiniteNP 5707 5717	some cases
T173	DefiniteNP 5914 5923	the cause
T174	DefiniteNP 5975 5992	the possible need
T175	ZeroArticleNP 6038 6054	LETAIRIS therapy
T176	DefiniteNP 6170 6185	the possibility
T177	ZeroArticleNP 6119 6126	therapy
T178	ZeroArticleNP 6132 6151	vasodilating agents
T179	IndefiniteNP 6297 6312	a 6-month study
T180	IndefiniteNP 6316 6354	another endothelin receptor antagonist
T181	ZeroArticleNP 6392 6408	functional class
T182	DefiniteNP 6568 6580	the patients
T183	IndefiniteNP 6517 6526	a decline
T184	DefiniteNP 6687 6702	the sperm count
T185	DefiniteNP 6751 6773	the subsequent 6 weeks
T186	DefiniteNP 6820 6835	the sperm count
T187	DefiniteNP 6949 6965	the normal range
T188	PersonalPronoun 7168 7170	it
T189	IndefiniteNP 7249 7266	an adverse effect
T190	DemonstrativeNP 7060 7074	these findings
T191	ZeroArticleNP 7135 7166	endothelin receptor antagonists
T192	ZeroArticleNP 7195 7226	endothelin receptor antagonists
T193	IndefiniteNP 7372 7409	other endothelin receptor antagonists
T194	DefiniteNP 7500 7519	the first few weeks
T195	DemonstrativeNP 7463 7478	These decreases
T196	DefiniteNP 7575 7592	The mean decrease
T197	DefiniteNP 7682 7720	the 12-week placebo-controlled studies
T198	DemonstrativeNP 7645 7659	those patients
T199	DefiniteNP 7822 7837	the lower limit
T200	IndefiniteNP 7808 7815	a value
T201	IndefiniteNP 7872 7884	all patients
T202	PersonalPronoun 8044 8046	it
T203	DefiniteNP 7988 7997	The cause
T204	DefiniteNP 8001 8013	the decrease
T205	DefiniteNP 8106 8140	the long-term open-label extension
T206	DefiniteNP 8144 8176	the two pivotal clinical studies
T207	ZeroArticleNP 8564 8580	LETAIRIS therapy
T208	IndefiniteNP 8652 8685	a clinically significant decrease
T209	IndefiniteNP 8716 8728	other causes
T210	ZeroArticleNP 8783 8800	DRUG INTERACTIONS
T211	DefiniteNP 8983 8991	the dose
T212	IndefiniteNP 8886 8918	an approximately 2-fold increase
T213	IndefiniteNP 9175 9199	an about 2-fold increase
T214	DefiniteNP 9293 9301	the dose
T215	DefiniteNP 9360 9374	the brand name
T216	DefiniteNP 9448 9484	the endothelin type-A (ETA) receptor
T217	IndefiniteNP 9392 9425	an endothelin receptor antagonist
T218	DefiniteNP 9486 9503	The chemical name
T219	PersonalPronoun 9604 9606	It
T220	IndefiniteNP 9611 9630	a molecular formula
T221	IndefiniteNP 9649 9667	a molecular weight
T222	PersonalPronoun 9679 9681	It
T223	DefiniteNP 9731 9753	the (S ) configuration
T224	IndefiniteNP 9691 9713	a single chiral center
T225	PersonalPronoun 9814 9816	It
T226	IndefiniteNP 9820 9837	a carboxylic acid
T227	IndefiniteNP 9843 9848	a pKa
T228	ZeroArticleNP 9910 9927	aqueous solutions
T229	ZeroArticleNP 9963 9980	aqueous solutions
T230	DefiniteNP 9998 10013	the solid state
T231	ZeroArticleNP 10126 10151	10 mg film-coated tablets
T232	DefiniteNP 10188 10199	The tablets
T233	DefiniteNP 10208 10242	the following inactive ingredients
T234	DefiniteNP 10339 10350	The tablets
T235	IndefiniteNP 10372 10390	a coating material
T236	DistributiveNP 10510 10521	Each square
T237	ZeroArticleNP 10528 10548	pink LETAIRIS tablet
T238	DistributiveNP 10579 10588	Each oval
T239	ZeroArticleNP 10595 10615	pink LETAIRIS tablet
T240	ZeroArticleNP 10647 10663	LETAIRIS tablets
